POS-692 Euglycemic Diabetic Ketoacidosis Related to SGLT2 Inhibitor Use in Kidney Transplant Patient with Squamous Cell Carcinoma

by F. ALKINDI, M. Al Hakim, A. Chaaban, Y. Boobes
Published 2021-04-01

POS-691 Clinical Characteristics and Outcomes of COVID-19 Infected Kidney Transplant Recipients

by F. ALKINDI, A. Al Hammadi, M. Al Hakim, A. Chaaban, A. George, M. Saad, M. Al Seiari, Y. Boobes
Published 2021-04-01

POS-525 Recurrent Hospitalization in Hemodialysis Patients: Is It Preventable Or Manageable?

by F. Hazin, F. AlKindi, S. Al Abdullah, H. Choker, M. FarajAllah, Y. Boobes, M. Al Hakim, A. Chaaban
Published 2021-04-01

POS-505 Posterior Reversible Encephalopathy Syndrome in Dialysis Patients and Kidney Disease

by F. AlKindi, A. AlKhoori, M. Al Hakim, A. Chaaban, H. Eljack, M. Budruddin, K. Mzayen, I. Khan, Y. Boobes
Published 2021-04-01

POS-690 Outcomes of Malignancy in Kidney Transplant Recipients

by F. ALKINDI, M. Al Blooshi, A. Al-Awadhi, A. Alam, M. Al Hakim, A. Chaaban, H. Eljack, M. Budruddin, K. Mzayen, I. Khan, Y. Boobes
Published 2021-04-01